The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Veen, R. C.
Right arrow Articles by Holland, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Veen, R. C.
Right arrow Articles by Holland, S. M.
The Journal of Immunology, 2000, 164: 5177-5183.
Copyright © 2000 by The American Association of Immunologists

Superoxide Prevents Nitric Oxide-Mediated Suppression of Helper T Lymphocytes: Decreased Autoimmune Encephalomyelitis in Nicotinamide Adenine Dinucleotide Phosphate Oxidase Knockout Mice1

Roel C. van der Veen2,*, Therese A. Dietlin*, Florence M. Hofman{dagger}, Ligaya Pen*, Brahm H. Segal{ddagger} and Steven M. Holland{ddagger}

Departments of * Neurology and {dagger} Pathology, University of Southern California School of Medicine, Los Angeles, CA 90033; and {ddagger} Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
NO, which suppresses T cell proliferation, may be inactivated by superoxide (O2-) due to their strong mutual affinity. To examine this possibility, preactivated Th clones were cocultured with stimulated macrophages. PMA neutralized the inhibitory activity of NO, which was dependent on extracellular O2- production. In contrast, macrophages from p47phox -/- (pKO) mice, which lack functional NADPH oxidase, retained their NO-dependent inhibition of T cell proliferation upon stimulation with PMA, indicating that NADPH oxidase is the major source of NO-inactivating O2- in this system. To examine the NO-O2- interaction in vivo, the role of NADPH oxidase in experimental autoimmune encephalomyelitis was studied in pKO mice. No clinical or histological signs were observed in the pKO mice. Neither a bias in Th subsets nor a reduced intensity of T cell responses could account for the disease resistance. Although spleen cells from pKO mice proliferated poorly in response to the immunogen, inhibition of NO synthase uncovered a normal proliferative response. These results indicate that NO activity may play a critical role in T cell responses in pKO mice and that in normal spleens inhibition of T cell proliferation by NO may be prevented by simultaneous NADPH oxidase activity.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The free radical NO is produced by NO synthases (NOS)3 by converting L-arginine to L-citrulline, a process that can be inhibited by analogues of L-arginine, such as N-monomethyl-L-arginine (L-NMA). Inducible NOS (iNOS) expression is induced by LPS, TNF-{alpha}, IFN-{gamma} (1), cAMP (2), IL-1, and PGE2 (3). Despite extensive knowledge about NO regulation, the role of NO in tissue inflammation is controversial, as illustrated by studies involving the animal model for multiple sclerosis, experimental allergic encephalomyelitis (EAE). Some investigators concluded that NO is involved in the pathogenesis of EAE (4, 5, 6, 7, 8, 9, 10, 11, 12), while others reported protective effects of NO (13, 14, 15, 16).

It is improbable that NO forms a major effector molecule during CNS inflammation and tissue damage, because NO is only a weak oxidant and reacts more rapidly as an antioxidant (17). NO may be involved in protection against cytokine-induced systemic damage (18), as well as inhibition of leukocyte adhesion and migration through the endothelial cell layer (19). In addition, NO has been implicated as a major macrophage-derived immunosuppressive factor for T cell immunity (20, 21). NO functions as a powerful inhibitor of T cell proliferation (22, 23) and also inhibits NF-{kappa}B activation (24). Surprisingly, iNOS-deficient mice express increased EAE severity compared with wild-type mice (25, 26), supporting a protective role for NO.

NO can be transformed by reacting with another enzymatically produced free radical, superoxide (O2-) to form the pro-oxidant peroxynitrite (ONOO-) (27, 28, 29, 30), which has been implicated in EAE (31, 32, 33). The extremely strong reaction between the free radicals NO and O2-, which occurs three times faster than the rate at which superoxide dismutase (SOD) scavenges O2- (27), could regulate NO’s activity and at the same time be responsible for the widely studied cytotoxic effects of NO. The studies described here focus on the regulation of NO’s activity by O2-, but not on the role of ONOO-. Thus, the fate of NO may determine whether or not it provides immunoregulatory protection. This concept was tested by studying the regulation of NO activity by simultaneous O2- production by macrophages. As demonstrated earlier with chemical NO donors in the absence of macrophages, NO strongly inhibits the proliferation of activated Th cell clones directly, without reducing their cytokine production (34). This characteristic was used in the current studies for the quantification of the functional activity of macrophage-derived NO.

In humans, mutations in any of the four structural proteins of the NADPH oxidase lead to chronic granulomatous disease, an inherited immunodeficiency in which children develop recurrent, severe, life-threatening bacterial and fungal infections and tissue granuloma formation. NADPH oxidase produces O2- and forms an essential factor in the protection against infections (35), but its role in immune regulation or in EAE has not been studied. Besides a potential cytotoxic role for O2- or its derivatives during inflammation, NADPH oxidase may regulate the activity of macrophage-derived NO and could be important in EAE. To study this, we used mice with a targeted deletion in p47phox, an essential component of the NADPH oxidase enzyme complex. The results indicate that the NO-dependent inhibitory activity of macrophages is reversed by NADPH oxidase, which could be involved in the resistance of p47phox knockout (pKO) mice to active EAE induction.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials

The NOS inhibitor L-NMA and its inactive isomer D-NMA, as well as the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP) were purchased from Alexis (San Diego, CA). Recombinant mouse IFN-{gamma} was obtained from PharMingen (San Diego, CA). All other reagents were obtained from Sigma (St. Louis, MO). The synthetic peptide derived from myelin-oligodendrocyte glycoprotein (MOG) sequence 35–55 was produced by the Microchemical Core Facility at the University of Southern California Comprehensive Cancer Center.

Mice

Gene deletants were created in the 129 background strain and bred on C57BL/6 as described (35). Heterozygous deletants were crossed back onto the C57BL/6 background and then intercrossed. Homozygous p47phox deletants and wild-type (WT) littermates were used for the described experiments. SJL mice were obtained from The Jackson Laboratory (Bar Harbor, ME).

T cells

SJL-derived T cell clones 39A1 and 41D5 are specific for the myelin proteolipid protein peptide 139–151, with identical fine-specificity for individual amino acids within this sequence (36). Clone 39A1 belongs to the Th1 subset, while 41D5 represents the Th2 subset. The T cell clones are maintained by the periodical stimulation with irradiated spleen cells and Ag as described (37). For the experiments described here, resting T cells were stimulated with immobilized anti-CD3 mAb (PharMingen) for 20 h as described previously (37).

Macrophage-T cell cocultures

Peritoneal macrophages (PEC) were harvested 3 days following the injection of 2.5 ml thioglycollate medium (4%) and cultured for 2 h in microtiter plates at 0.8 x 105 large, granulated mononuclear cells per well, followed by removal of the nonadherent cells. Culture medium for macrophages consisted of high-glucose DMEM (Life Technologies, Gaithersburg, MD) supplemented with 10% FCS, 15 mM HEPES, 2.5 mM L-glutamine, penicillin (100 U/ml), and streptomycin (100 µg/ml). To induce NO production in macrophages, the cells were stimulated with LPS (0.1 µg/ml) and recombinant mouse IFN-{gamma} (10 U/ml) for 20 h. After washing the adherent PEC cultures, anti-CD3-stimulated T cells were washed and transferred to the PEC cultures at 105 T cells per well. To study the effect of O2- on NO activity, some cultures received PMA (0.2 µg/ml) at the onset of the coculture, which induces immediate O2- production by the NO-producing PEC. Because the activated T cells were added at the same time, the effect of NO on the T cells can be examined in the presence or absence of O2-. The cocultures were simultaneously pulsed with [3H]TdR (0.5 µCi/well) and incubated for 16 h before harvesting the cells onto fiberglass filters and counting in a scintillation counter. Results are presented as the total [3H]TdR incorporation in cpm x 10-3.

O2- production

PEC, cultured for 24 h at 106 cells per well, were washed and stimulated with PMA (0.2 µg/ml) in DMEM in the presence of cytochrome c (200 µg/ml). After 1 h, the supernatants were centrifuged at 15,000 rpm and the absorbence at 550 nm was measured.

Immunization of mice

pKO and WT mice were immunized s.c. with 300 µg MOG35–55 in CFA containing 500 µg Mycobacterium tuberculosis HR37A, in a volume of 200 µl, divided over two or three dorsal sites. In addition, pertussis toxin (200 ng) was injected i.p. The immunization was repeated after 7 days. A total of 11 mice from each strain was immunized, divided over two separate experiments with five or six mice from each strain. The mice were scored daily as follows: 0, no symptoms; 1, weak tail; 2, paraparesis; 3, severe paraparesis including occasional leg dragging; 4, paralysis; 5, moribund.

Histology

Brain and spinal cord were embedded and frozen in liquid nitrogen. Cryostat sections (6–8 µm) were prepared and fixed in acetone and subsequently stained in hematoxylin for 1 min.

Lymphoid cell proliferation

Dissociated lymph node cells (LNC) or spleen cells were cultured at 4 x 105 mononuclear cells per well with MOG35–55 (20 µg/ml) for 64 h, with the last 16 h in the presence of [3H]TdR (0.5 µCi). The cells were harvested to measure the incorporated [3H]TdR. Either the total incorporation or the stimulation index (total over background incorporation) is shown, as indicated.

Cytokine production

Supernatants from cultures described above were harvested after 48 h and assayed for cytokines by ELISA using Ab pairs and standards from PharMingen, according to the manufacturer’s procedure. Net cytokine production was expressed as the difference between Ag-stimulated and background levels.

Nitrite/nitrate production

Combined nitrite and nitrate levels were measured in culture supernatants using a Cayman’s kit (Alexis), according to the manufacturer’s instructions. The culture medium itself contained low nitrate levels.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Macrophage-derived NO blocks T cell proliferation

To evaluate the efficiency at which macrophage-derived NO inhibits Th cell proliferation, Th1 cells were activated with immobilized anti-CD3 mAb and subsequently transferred to cultures of adherent PEC, which had previously been stimulated with LPS and IFN-{gamma}, as described in Materials and Methods. To determine the contribution of NO toward the inhibition of T cells by macrophages, the NOS inhibitor L-NMA was added to some cultures. Fig. 1GoA shows the effectiveness of L-NMA in inhibiting NO production by stimulated macrophages. The concentrations of L-NMA that completely inhibited NO production (>=0.5 mM) also induced optimal T cell proliferation, whereas the inactive isomer D-NMA was without effect (Fig. 1GoB). Similar data were obtained with Th2 cells, while the contribution of the macrophages in the total cell proliferation was minimal (results not shown). The procedure described here was used in the following experiments to examine the regulation of NO’s functional activity by O2-.



View larger version (29K):
[in this window]
[in a new window]
 
FIGURE 1. NO-dependent inhibition of T cells by activated macrophages is reversed by O2-. A, L-NMA was added during the stimulation of SJL-derived PEC with LPS and IFN-{gamma}. After 2 days, supernatants were harvested and examined for nitrite content. B, L-NMA or D-NMA were included in cocultures of stimulated adherent PEC and preactivated Th1 cells. Cultures were pulsed and harvested as described in Materials and Methods. C, Normal adherent SJL-derived PEC were stimulated with IFN-{gamma} and LPS, while Th1 cells were stimulated with anti-CD3 mAb separately (see Materials and Methods). After 20 h, the stimulated T cells were transferred to the PEC cultures in the presence of high (hi, 0.5 mM) or low (lo, 0.05 mM) levels of L-NMA (NMA), 200 ng/ml PMA, or 300 U/ml SOD as indicated and pulsed with [3H]TdR simultaneously. Results shown are representative of six experiments. Insert, PMA-induced reduction of cytochrome c indicates extracellular O2- production, because it is inhibited by SOD. D, O2- produced by macrophages does not directly activate T cells. Th1 cells were stimulated with anti-CD3 mAb in the presence (top) or absence (bottom) of the inhibitory NO donor SNAP at 0.1 mM. After 20 h, the T cells were transferred to wells containing unstimulated adherent PEC and L-NMA (1 mM), as well as PMA (200 ng/ml) or SOD (300 U/ml), as indicated. These cocultures were pulsed immediately and incubated as described in Materials and Methods.

 
O2- neutralizes the inhibitory effect of NO

Because O2- has a strong affinity for NO, we hypothesized that simultaneous O2- production may prevent the inhibitory effect of NO on T cell proliferation. Adherent PEC, previously stimulated to induce NO production, were treated with PMA, which induces O2- production in the PEC (see insert in Fig. 1GoC) immediately following the addition of the activated T cells to the PEC. In the absence of PMA, the PEC again completely inhibited the proliferation of the T cells, which was reversed by the addition of high levels of L-NMA, as expected (see Fig. 1GoC). The [3H]TdR incorporation of the PEC alone was negligible (<1 x 103 cpm), also in the presence of L-NMA or PMA. In the presence of maximal NO production by the macrophages, i.e., in the absence of L-NMA, PMA had no significant effect on T cell proliferation. However, in the presence of a low level of L-NMA, which by itself induced only a slight increase in T cell proliferation, a substantial increase was induced when PMA was added simultaneously (see Fig. 1GoD). Apparently, a submaximal NO concentration was required to observe PMA’s effect. The addition of an NOS inhibitor forms a more sensitive tool in the regulation of NO production than variations in the concentration of the stimulants LPS and IFN-{gamma}; thus, the optimal concentration of L-NMA to help uncover T cell proliferation by PMA varied between experiments from 0.025 to 0.05 mM (results not shown).

These results indicate that PMA induced a process that neutralized NO’s inhibitory activity. Notably, the addition of SOD reversed PMA’s effect (see Fig. 1GoC), suggesting that O2- production was responsible for the inactivation of NO by PMA. To control for the effect of SOD, heat-inactivation of SOD neutralized its effect on T cell proliferation; furthermore, production of hydrogen peroxide by SOD was not responsible for its function, because catalase (60 U/ml) did not reverse the effect of SOD (results not shown).

A probable explanation for the inactivation of NO by O2- is the transformation of NO to ONOO-. So far, we and others have been unable to convincingly confirm the extracellular formation of ONOO- by macrophages in vitro. Therefore, an alternative explanation for the above described results was examined, i.e., whether macrophage-derived O2- could enhance T cell proliferation directly, thus overriding the effect of NO without reacting with it. To address this question, the production of NO and O2- were separated over time to prevent their interaction. This was approached by performing the initial anti-CD3 mAb-induced T cell stimulation in the presence of the NO donor SNAP, which inhibits T cell proliferation for at least 40 h (34). The NO-treated T cells were subsequently transferred to adherent PEC cultures in the presence of L-NMA to prevent the production of NO by the macrophages. In the absence of NO production, a direct effect of O2- from PMA-activated PEC on T cell proliferation was not detected, neither with NO-pretreated nor with uninhibited T cells (Fig. 1GoD). Therefore, these experiments demonstrate that macrophage-derived O2- did not directly stimulate the proliferation of the T cells. Instead, it can be concluded from the results in Fig. 1GoC that O2- prevents the profound inhibition of T cell proliferation by macrophage-derived NO, probably by reacting with NO. The studies described here raise the possibility that T cell proliferation can be regulated by the balance between O2- and NO.

Role of NADPH oxidase in the regulation of NO activity

Because extracellular SOD reversed the effect of PMA on NO activity, and because O2- cannot readily penetrate the cell membrane, O2- appears to be produced extracellularly, where it is thought to inactivate NO. Because a major source for extracellular O2- production is NADPH oxidase, the regulation of NO’s activity toward T cell proliferation by macrophages from NADPH oxidase-deficient (p47phox -/- or pKO) mice was examined.

Cocultures of prestimulated PEC and preactivated T cells were incubated as described above. Despite MHC incompatibility, stimulated PEC from both WT and pKO mice inhibited T cell proliferation equally well, which was reversed by high levels of L-NMA, as expected (Fig. 2Go). In the presence of low levels of L-NMA, stimulation with PMA reversed the inhibitory effect of NO in PEC from WT mice, similar to results shown in Fig. 1Go. However, the addition of PMA to PEC derived from pKO mice had no stimulatory effect on T cell proliferation. This indicates that the lack of functional NADPH oxidase results in the preservation of NO activity and confirms that O2- inactivates NO in normal PEC. In addition, these results confirm that in the presence of activated macrophages, PMA does not directly stimulate the T cells. Therefore, the results described here indicate that O2- production by NADPH oxidase regulates the activity of NO and thus T cell proliferation.



View larger version (27K):
[in this window]
[in a new window]
 
FIGURE 2. Cells from NADPH oxidase-deficient mice do not neutralize NO activity. Cocultures were performed as described in Fig. 1GoA, using stimulated PEC derived from WT or NADPH oxidase-deficient (pKO) mice as indicated, together with activated Th1 cells. The [3H]TdR incorporation of the T cells incubated alone was 16,529 ± 1,114 x 103 cpm. Results are representative of five independent experiments.

 
Role of NADPH oxidase in EAE

To study the role of NADPH oxidase in active EAE induction, 11 mice from pKO and WT strains were immunized with MOG35–55. The WT mice developed modest (three mice with clinical score <=3) or severe (seven mice with clinical score >=4) EAE, with only one WT mouse showing no obvious signs of EAE. In contrast, none of the 11 pKO mice showed any clear signs of EAE (see Fig. 3Go). Some pKO mice received a clinical score of 1 on a few occasions, only to indicate that they did not lift their tail during the observation, although tail weakness was not obvious otherwise. Histological examination of the CNS of the immunized pKO mice revealed normal tissue with no apparent inflammatory cells. In contrast, WT mice exhibited extensive perivascular infiltration of mainly mononuclear leukocytes typical of EAE, which generally correlated with clinical disease activity (results not shown).



View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 3. EAE in NADPH oxidase-deficient mice. A, Course of the mean clinical score in pKO mice and WT littermates. Eleven mice from both strains were immunized twice with MOG35–55. Day numbering started after the second immunization. B, Average maximal score. The difference between WT and pKO mice is highly significant (p = 0.0005, Student’s t test).

 
Normal induction of immune responses in pKO mice

To compare the intensity of the immune response to the encephalitogen, which is essential for the development of EAE, the response of lymphoid cells from both mouse strains to MOG in vitro was examined. As shown in Fig. 4GoA, similar proliferative responses were observed in LNC from pKO and WT mice. In addition, the cytokine production by spleen cells in response to MOG was comparable as well. A strong IFN-{gamma} production was observed in both pKO and WT mice (see Fig. 4GoB). In both strains, IL-10 production was weak, while IL-4 or IL-5 production in response to MOG was undetectable (results not shown). These results indicate that the immune response generated in the lymph nodes of pKO and WT mice was both quantitatively and qualitatively similar. Therefore, neither the intensity nor the type of immune response could explain the absence of EAE in the pKO mice.



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 4. Antigenic stimulation in lymphoid tissue obtained from MOG35–55-immunized pKO and WT mice. A, Proliferation of LNC stimulated with MOG35–55. The results shown are representative data from six mice from each strain, obtained at different times between day 12 and 55 p.i. B, Net IFN-{gamma} production by MOG35–55-stimulated spleen cells. The levels shown were averaged from six mice from each strain.

 
Enhanced NO activity in pKO mice

The resistance of pKO mice to EAE indicates that NADPH oxidase is essential for disease development. This may reflect the deleterious effects of reactive oxygen intermediates, or it may indicate a central role for ONOO-. In contrast, O2- may also function to prevent the NO-dependent inhibition of T cell proliferation, as observed with pKO macrophages in vitro. This possibility was supported by results obtained with the in vitro activation of spleen cells from immunized pKO mice, which in contrast to their LNC, generally proliferated poorly in response to MOG, whereas WT spleen cells in general responded well (Fig. 5GoA). In contrast, the cytokine production by MOG-stimulated spleen cells from pKO mice was similar to that of WT mice, as shown above in Fig. 4Go. This pattern of T cell responses (no proliferation, but normal cytokine production) is reminiscent of the effect of NO on T cell activity (34). Indeed, the addition of a NOS inhibitor uncovered a good proliferative response to MOG35–55 in spleen cell cultures derived from the pKO mice, raising it to a similar level as in WT spleen cells (Fig. 5Go, B and C). The lower degree of Ag-specific proliferation in pKO spleens could not be explained by increased NO production, because the total nitrite plus nitrate levels generated by pKO or WT spleen cultures in response to Ag were similar (Fig. 5GoD). This may indicate a higher degree of interaction between NO and O2-, resulting in a lower level of functional NO in WT compared with KO mice, which is consistent with the proliferation data. Comparison of nitrite vs nitrate levels was inconclusive and requires more study. In addition, these results imply that immune spleen cell cultures increased their NO production upon the addition of Ag, resulting in poor T cell proliferation in pKO splenic cultures.



View larger version (32K):
[in this window]
[in a new window]
 
FIGURE 5. Enhanced NO activity in pKO spleen cells from MOG-immunized mice. A, Proliferation of dissociated spleen cells induced by MOG35–55. The spleens used here were derived from the same individual mice as the lymph nodes used for the data shown in Fig. 4GoA. B, Proliferation induced by MOG35–55 (20 µg/ml) in the presence of the NOS inhibitor L-NMA (1 mM). C, Average stimulation index of spleen cells from seven pKO and seven WT mice in response to MOG35–55 with or without L-NMA. D, NO production during MOG-specific spleen cell stimulation. Combined nitrite/nitrate levels, after subtraction of background levels without Ag, were averaged from four mice of each strain.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Although the interaction between NO and O2- was discovered even before the identification of NO as endothelial relaxation factor (38) and has since been studied extensively (27, 28, 29, 30, 31, 32, 33, 39), its effect on NO’s immunoregulatory activity has largely been overlooked. NO forms a strong inhibitor of T cell proliferation, but, as shown here, NO’s inhibitory activity can be neutralized by simultaneous O2- production from NADPH oxidase.

In the current studies, PMA was used to induce immediate O2- production in stimulated, NO producing macrophages, which resulted in the prevention of NO’s inhibitory activity. As a control, it was shown that in the presence of NO, PMA did not enhance T cell proliferation directly, as demonstrated convincingly with cultures containing NADPH oxidase-deficient macrophages, nor could PMA overcome high levels of NO from normal macrophages. This is confirmed by earlier studies examining the inhibition of T cell proliferation by a chemical NO donor (34). Apparently, NO inhibits T cell proliferation downstream of protein kinase C activation by PMA and leaves cytokine production by the T cells virtually intact.

The presence of low levels of L-NMA was important to observe PMA’s effect on T cell proliferation, because in the absence of L-NMA, PMA only slightly inactivated NO. Maximal NO production may overwhelm or simply inhibit O2- production (40). The optimal concentration of L-NMA varied slightly between experiments. Therefore, parallel experiments were routinely performed with different concentrations of L-NMA, of which usually one concentration was optimal. Apparently, the balance between O2- and NO is delicate in this simplified system, comprised of purified macrophages and T cells. However, the results with ex vivo-stimulated spleen cells from immunized mice indicate that this balance can be reached in a more physiological system, suggesting that NADPH oxidase may inhibit NO’s activity and thus may uncover T cell proliferation in vivo as well.

The demonstration of extracellular ONOO- formation by cells in vitro as a consequence of the extremely high affinity between NO and O2- (27, 28), although likely to occur, has so far been inconclusive. Therefore, an alternative explanation of the results was examined, i.e., that O2- may directly stimulate T cell proliferation, even in the presence of inhibitory NO levels without actually interacting with NO. However, O2- from PMA-treated PEC caused only a marginal increase in NO-pretreated Th cell proliferation, which was not significantly reversed by SOD. These studies indicated that O2- produced by PEC was not directly involved in the stimulation of the T cells. Instead, O2- appears to inactivate NO, a strong inhibitor of T cell proliferation. As a consequence of the transformation of NO by O2-, other regulatory functions of NO may be impaired as well. These include inactivation of macrophages (20, 21) and the inhibition of lipid peroxidation (41, 42), which was demonstrated using purified myelin as well (29). These features render the preservation of NO activity potentially important during CNS inflammation.

In this report, the major source of NO-inactivating O2- was identified as NADPH oxidase. Therefore, other oxidases appear not to contribute substantially to the NO-neutralizing O2- production. Possibly, the localization, timing, and amount of O2- production are crucial. Because neither O2- nor exogenous SOD are membrane permeable, it can be concluded that the SOD-inhibited O2- was produced extracellularly. This suggests that ONOO- formation also occurs extracellularly. A schematic representation of the possible sequence of events involved in either the preservation of functional NO or its transformation to ONOO- is shown in Fig. 6Go. Intracellularly produced NO diffuses freely through the cell membrane, and, if unaffected by O2- (due to the presence of SOD or to a mutation or inactivity in NADPH oxidase), NO inhibits T cell proliferation. However, when NADPH oxidase is activated simultaneously, O2- is formed close to the extracellular face of the cell membrane. Here, it presumably interacts with NO molecules that have just passed through the cell membrane on their way out of the cell. Besides the presumed formation of ONOO- extracellulary, this results in the prevention of NO-dependent inhibition of T cell proliferation.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 6. Schematic representation of the regulation of NO activity from macrophages (M{phi}) by O2- from NADPH oxidase. See Discussion for explanation. A compound with a dot indicates a free radical. Arrows with filled head indicate pathways; arrows with open head indicate an increase (up) or a decrease (down) in the process aligned by an arrow.

 
ONOO- reportedly inhibits T cell proliferation (43), which seems to contradict the results described here, where simultaneous production of NO and O2- resulted in enhanced proliferation, indicating that ONOO- formation reverses rather than induces inhibition of T cell proliferation. The difference between the two studies may be explained by the use of a single high dose of preformed ONOO-, which also induced apoptosis in activated T cells (43), whereas in the current system, NO and ONOO- formation occurs gradually, with a low concentration at any given time (estimated at <5 nM) and a limited effect on cell viability (34, 44).

Notably, results in this report further indicate that the interaction between NO and O2- may be important during immune responses in vivo, because spleen cells from immune mice demonstrated reduced Ag-specific T cell proliferation ex vivo when NADPH oxidase was disrupted and unable to regulate NO activity. LNC from immunized pKO mice responded to Ag in a similar fashion as those from WT mice as early as 12 days p.i., indicating the general absence of regulation by NO in lymph nodes, also at early time points after immunization. Thus, it can be concluded that the absence of Ag-specific immune responses in pKO spleens is a local, not a systemic, phenomenon, possibly reflecting a higher concentration of macrophages in the spleen. A strong indication of the significance of immune regulation by NO and O2- could be found in the virtually complete resistance of pKO mice to actively induced EAE. In light of their inhibited spleen cell responses, this may indicate a form of immunodeficiency as a consequence of excessive NO activity in the pKO mice. Inhibition of NO production in pKO mice may be a way to approach this issue. However, the contradictory results in the literature concerning the effect of NO inhibition on EAE development indicate that this approach has dualistic effects, possibly related to the fact that NO has a role in ONOO- formation at inflammatory sites as well. Because a good proliferative response could be demonstrated in lymphoid tissue from EAE-resistant pKO mice, it appears that their genetic defect does not affect the induction, but rather the execution of the immune response that normally leads to EAE development. This is currently under investigation using cell transfers between pKO and WT mice.

The results described here indicate that in the absence of NADPH oxidase, a spleen cell subpopulation produces enough functional NO during an immune response to inhibit the proliferation of T cells. These NO-producing cells may be the same as the recently described splenic ScaI/Mac1+ macrophages, which suppress T cell responses through NO activity (45). During tissue inflammation, similar cells may accumulate, as exemplified by the effect of elicited PEC on T cell proliferation in vitro.

An implication of the results described here is that a T cell regulatory role for NO is less prevalent in draining lymph nodes, where immune responses are initiated. However, although the T cells in the lymph nodes of immunized pKO mice are stimulated, they appear unable to induce EAE in these mice. If NO is involved in the resistance to EAE in the pKO mice, the site of this activity is unclear, but does not seem to include the draining lymph nodes. Furthermore, if, as suggested here, the inhibition of EAE in the pKO mice is regulated peripherally, it may be concluded that activated T cells do not directly migrate from the draining lymph nodes to the CNS, but instead may first be checked elsewhere, possibly in the spleen.

Another implication is that during an immune response in normal spleen cells, both O2- and NO are produced as a consequence of Ag recognition by T cells. Macrophages produce high levels of NO following their Ag-specific stimulation of Th1, but not Th2, cells, resulting in the inhibition of T cell proliferation.4 Furthermore, the balance between O2- and NO may dictate the extent of an immune response in vivo, either at the site of inflammation, e.g., in the CNS, or peripherally, e.g., in the spleen. It is suggested here that this balance regulates the extent of an immune response, with T cell suppression resulting from excess NO, but T cell proliferation following increased O2- production by NADPH oxidase, even during NO production. Besides preventing NO’s T cell regulatory activity, O2- transforms NO from an immunoregulatory factor into the oxidative compound ONOO-, which could be involved locally in tissue damage during inflammation. However, the data reported here suggest that NO may perform an important immunoregulatory role peripherally as well, during the generation of an immune response. On the same note, it can be hypothesized that excessive functional NO activity without simultaneous O2- production could inhibit protective T cell responses, e.g., during immunocompromised conditions. In this case, O2- production and thus NO inactivation would be beneficial, allowing T cell proliferation to occur. In conclusion, the interaction between NO and O2- may play a central role in the control over the execution of immune responses in general (possibly in the spleen), without affecting the induction of immune responses in the lymph nodes. Although an essential role for NADPH oxidase in tissue damage during CNS inflammation has not been ruled out, these studies indicate that NADPH oxidase may be essential to allow the development of a strong immune response, such as occurs during EAE.


    Acknowledgments
 
We thank Sonia Q. Garcia for her patient and skillful assistance and Drs. G. Dennert and S. A. Stohlman for critical comments.


    Footnotes
 
1 This work was supported in part by a grant from the National Multiple Sclerosis Society. Back

2 Address correspondence and reprint requests to Dr. Roel C. van der Veen, University of Southern California School of Medicine, Department of Neurology, 1333 San Pablo Street, MCH 142, Los Angeles, CA 90033. Back

3 Abbreviations used in this paper: NOS, NO synthase; iNOS, inducible NOS; L(D)-NMA, N-monomethyl-L(D)-arginine; EAE, experimental autoimmune encephalomyelitis; O2-, superoxide, SOD, superoxide dismutase; SNAP, S-nitroso-N-acetyl-D,L-penicillamine; pKO, p47phox-/-; PEC, peritoneal macrophage; WT, wild type; LNC, lymph node cell; MOG, myelin-oligodendrocyte glycoprotein; ONOO-, peroxynitrite. Back

4 R. C. van der Veen, T. A. Dietlin, L. Pen, J. Dixon Gray, and F. M. Hofman. Induction of nitric oxide during antigenic stimulation of T helper 1 cells by macrophages regulates T cell proliferation. Submitted for publication. Back

Received for publication October 14, 1999. Accepted for publication March 6, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Langermans, J. A. M., M. E. B. van der Hulst, P. H. Nibbering, P. S. Hiemstra, L. Fransen, R. van Furth. 1992. IFN-{gamma}-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-{alpha}. J. Immunol. 148:568.[Abstract]
  2. Imai, T., Y. Hirata, K. Kanno, F. Marumo. 1994. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J. Clin. Invest. 93:543.
  3. Gaillard, T., A. Mulsch, H. Klein, K. Decker. 1992. Regulation by prostaglandin E2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol. Chem. Hoppe-Seyler 373:897.[Medline]
  4. Merrill, J. E., L. J. Ignarro, M. P. Sherman, J. Melinek, T. E. Lane. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:2132.[Abstract]
  5. Ding, M., M. Zhang, J. L. Wong, N. E. Rogers, L. J. Ignarro, R. R. Voskuhl. 1998. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160:2560.[Abstract/Free Full Text]
  6. Bagasra, O., F. H. Michaels, Y. M. Zheng, L. E. Bobroski, S. V. Spitsin, Z. F. Fu, R. Tawadros, H. Koprowski. 1995. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 92:12041.[Abstract/Free Full Text]
  7. Bo, L., T. M. Dawson, S. Wesselingh, S. Mork, S. Choi, P. A. Kong, D. Hanley, B. D. Trapp. 1994. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:778.[Medline]
  8. Cross, A. H., T. P. Misko, R. F. Lin, W. F. Hickey, J. L. Trotter, R. G. Tilton. 1994. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:2684.
  9. Zhao, W., R. G. Tilton, J. A. Corbett, M. L. McDaniel, T. P. Misko, J. R. Williamson, A. H. Cross, W. F. Hickey. 1996. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:123.[Medline]
  10. Hooper, D. C., S. T. Ohnishi, R. Kean, Y. Numagami, B. Dietzschold, H. Koprowski. 1995. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA 92:5312.[Abstract/Free Full Text]
  11. Misko, T. P., J. L. Trotter, A. H. Cross. 1995. Mediation of inflammation by encephalitogenic cells: interferon {gamma} induction of nitric oxide synthase and cyclooxygenase 2. J. Neuroimmunol. 61:195.[Medline]
  12. Mitrovic, B., L. J. Ignarro, S. Montestruque, A. Smoll, J. E. Merrill. 1994. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61:575.[Medline]
  13. Zielasek, J., S. Jung, R. Gold, F. Y. Liew, K. V. Toyka, H. P. Hartung. 1995. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:81.[Medline]
  14. Ruuls, S. R., S. van der Linden, K. Sontrop, I. Huitinga, C. D. Dijkstra. 1996. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:467.[Medline]
  15. Gold, D. P., K. Schroder, H. C. Powell, C. J. Kelly. 1997. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 27:2863.[Medline]
  16. Cowden, W. B., F. A. Cullen, M. A. Staykova, D. O. Willenborg. 1998. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88:1.[Medline]
  17. Hogg, N., B. Kalyanaraman, V. Darley-Usmar. 1995. Oxidant and antioxidant effects of nitric oxide and superoxide in the vasculature. K. J. A. Davies, and F. Ursini, eds. The Oxygen Paradox 317.-324. Cleup University Press, Padora, Italy.
  18. Matthys, P., G. Froyen, L. Verdot, S. Huang, H. Sobis, J. Van Damme, B. Vray, M. Aguet, A. Billiau. 1995. IFN-{gamma} receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide. J. Immunol. 155:3823.[Abstract]
  19. Kubes, P., I. Kurose, D. N. Granger. 1994. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am. J. Physiol. 267:H931.[Abstract/Free Full Text]
  20. Mills, C. D.. 1991. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146:2719.[Abstract]
  21. Tomioka, H., H. Saito. 1991. Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents. J. Leukocyte Biol. 51:24.[Abstract]
  22. Albina, J. E., J. A. Abate, Jr W. L. Henry. 1991. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: role of IFN-{gamma} in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147:144.[Abstract]
  23. Krenger, W., G. Falzarano, Jr J. Delmonte, K. M. Snyder, J. C. Byon, J. L. Ferrara. 1996. Interferon-{gamma} suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease. Blood 88:1113.[Abstract/Free Full Text]
  24. Togashi, H., M. Sasaki, E. Frohman, E. Taira, R. R. Ratan, T. M. Dawson, V. L. Dawson. 1997. Neuronal (type 1) nitric oxide synthase regulates nuclear NFkB activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. USA 94:2676.[Abstract/Free Full Text]
  25. Sahrbacher, U. C., F. Lechner, H. P. Eugster, K. Frei, H. Lassmann, A. Fontana. 1998. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28:1332.[Medline]
  26. Fenyk-Melody, J. E., A. E. Garrison, S. R. Brunnert, J. R. Weidner, F. Shen, B. A. Shelton, J. S. Mudgett. 1998. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:2940.[Abstract/Free Full Text]
  27. Beckman, J. S., Y. Z .Ye, P. G. Anderson, J. Chen, M. A. Accavitti, M. M. Tarpey, C. R. White. 1994. Extensive nitration of protein tyrosines in human atherosclerosis, detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler 375:81.[Medline]
  28. Radi, R. J. S., K. M. Bush Beckman, B. A. Freeman. 1991. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288:481.[Medline]
  29. van der Veen, R. C., L. J. Roberts. 1999. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids. J. Neuroimmunol. 95:1.[Medline]
  30. Zingarellli, B., M. O’Connor, H. Wong, A. L. Salzman, C. Szabo. 1996. Peroxynitrite-mediated DNA stand breakage activates polyadenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol. 156:350.[Abstract]
  31. Hooper, D. C., O. Bagasra, J. C. Marini, A. Zborek, S. T. Ohnishi, R. Kean, J. M. Champion, A. B. Sarker, L. Bobroski, J.-L. Farber, et al 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA 94:2528.[Abstract/Free Full Text]
  32. van der Veen, R. C., D. R. Hinton, F. Incardonna, F. M. Hofman. 1997. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77:1.[Medline]
  33. Cross, A. H., P. T. Manning, M. K. Stern, T. P. Misko. 1997. Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J. Neuroimmunol. 80:121.[Medline]
  34. van der Veen, R. C., T. A. Dietlin, L. Pen, J. D. Gray. 1999. Nitric oxide inhibits the proliferation of T-helper 1 and 2 lymphocytes without reduction in cytokine secretion. Cell. Immunol. 193:194.[Medline]
  35. Jackson, S. H., J. I. Gallin, S. M. Holland. 1995. The p47phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182:751.[Abstract/Free Full Text]
  36. van der Veen, R. C., P.-J. Chen, M. McMillan. 1995. Myelin proteolipid protein-induced Th1 and Th2 clones express TCR with similar fine specificity for peptide and CDR3 homology despite diverse Vß usage. Cell. Immunol. 166:291.[Medline]
  37. van der Veen, R. C., S. A. Stohlman. 1993. Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:213.[Medline]
  38. Gryglewski, R. J., R. M. J. Palmer, S. Moncada. 1986. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454.[Medline]
  39. Grisham, M. B., D. Jourd’heuil, D. A. Wink. 1999. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 276:G315.[Abstract/Free Full Text]
  40. Clancy, R. M., J. Leszczynska-Piziak, S. B. Abramson. 1992. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90:1116.
  41. Hogg, N., B. Kalyanaraman, J. Joseph, A. Sruck, S. Parthasarathy. 1993. Inhibition of low-density lipoprotein oxidation by nitric oxide. Fed. Eur. Biochem. Soc. 334:170.
  42. Jessup, W., D. Mohr, S. P. Giese, R. T. Dean, R. Stocker. 1992. The participation of nitric oxide in cell-free and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim. Biophys. Acta 1180:73.[Medline]
  43. Brito, C., M. Naviliat, A. C. Tiscornia, F. Vuillier, G. Gualco, G. Dighiero, R. Radi, A. M. Cayota. 1999. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J. Immunol. 162:3356.[Abstract/Free Full Text]
  44. van der Veen, R. C., T. A. Dietlin, J. D. Gray, W. Gilmore. 2000. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells. Cell. Immunol. 199:43.[Medline]
  45. Johnson, B. D., C. A. Hanke, E. E. Becker, R. L. Truitt. 1998. ScaI+/Mac1+ nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro. Cell. Immunol. 189:149.[Medline]



This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Pastor, A. Minguela, W. Mi, and E. S. Ward
Autoantigen Immunization at Different Sites Reveals a Role for Anti-Inflammatory Effects of IFN-{gamma} in Regulating Susceptibility to Experimental Autoimmune Encephalomyelitis
J. Immunol., May 1, 2009; 182(9): 5268 - 5275.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Li, K. K. McKinstry, S. L. Swain, and D. K. Dalton
IFN-{gamma} Acts Directly on Activated CD4+ T Cells during Mycobacterial Infection to Promote Apoptosis by Inducing Components of the Intracellular Apoptosis Machinery and by Inducing Extracellular Proapoptotic Signals
J. Immunol., July 15, 2007; 179(2): 939 - 949.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. A. Dietlin, F. M. Hofman, B. T. Lund, W. Gilmore, S. A. Stohlman, and R. C. van der Veen
Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion
J. Leukoc. Biol., May 1, 2007; 81(5): 1205 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Snelgrove, L. Edwards, A. E. Williams, A. J. Rae, and T. Hussell
In the Absence of Reactive Oxygen Species, T Cells Default to a Th1 Phenotype and Mediate Protection against Pulmonary Cryptococcus neoformans Infection
J. Immunol., October 15, 2006; 177(8): 5509 - 5516.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Cai, M. R. Garrett, H. Meng, J. P. Rapp, and B. Joe
Are IA-2 and RESP18 Involved in Trait of Blood Pressure?
Hypertension, November 1, 2005; 46(5): e18 - e19.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Hultqvist, P. Olofsson, J. Holmberg, B. T. Backstrom, J. Tordsson, and R. Holmdahl
Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene
PNAS, August 24, 2004; 101(34): 12646 - 12651.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
M. Pao, E. A. Wiggs, M. M. Anastacio, J. Hyun, E. S. DeCarlo, J. T. Miller, V. L. Anderson, H. L. Malech, J. I. Gallin, and S. M. Holland
Cognitive Function in Patients With Chronic Granulomatous Disease: A Preliminary Report
Psychosomatics, June 1, 2004; 45(3): 230 - 234.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. H. Ramsey, I. M. Sigar, S. V. Rana, J. Gupta, S. M. Holland, G. I. Byrne, and J. D. Morrow
Inducible Nitric Oxide Synthase Regulates Production of Isoprostanes In Vivo during Chlamydial Genital Infection in Mice
Infect. Immun., December 1, 2003; 71(12): 7183 - 7187.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. E. Macphail, C. A. Gibney, B. M. Brooks, C. G. Booth, B. F. Flanagan, and J. W. Coleman
Nitric Oxide Regulation of Human Peripheral Blood Mononuclear Cells: Critical Time Dependence and Selectivity for Cytokine versus Chemokine Expression
J. Immunol., November 1, 2003; 171(9): 4809 - 4815.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-L. Chen, C.-T. Lee, Y.-C. Liu, J.-Y. Wang, H.-Y. Lei, and C.-K. Yu
House Dust Mite Dermatophagoides farinae Augments Proinflammatory Mediator Productions and Accessory Function of Alveolar Macrophages: Implications for Allergic Sensitization and Inflammation
J. Immunol., January 1, 2003; 170(1): 528 - 536.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yang, A. Panoskaltsis-Mortari, M. Shukla, B. R. Blazar, and I. Y. Haddad
Exuberant Inflammation in Nicotinamide Adenine Dinucleotide Phosphate-Oxidase-Deficient Mice After Allogeneic Marrow Transplantation
J. Immunol., June 1, 2002; 168(11): 5840 - 5847.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. A. Patton, A. C. La Flamme, J. A. Pedras-Vasoncelos, and E. J. Pearce
Central Role for Interleukin-4 in Regulating Nitric Oxide-Mediated Inhibition of T-Cell Proliferation and Gamma Interferon Production in Schistosomiasis
Infect. Immun., January 1, 2002; 70(1): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. H. Ramsey, I. M. Sigar, S. V. Rana, J. Gupta, S. M. Holland, and G. I. Byrne
Role for Inducible Nitric Oxide Synthase in Protection from Chronic Chlamydia trachomatis Urogenital Disease in Mice and Its Regulation by Oxygen Free Radicals
Infect. Immun., December 1, 2001; 69(12): 7374 - 7379.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L.-Y. Xu, J.-S. Yang, H. Link, and B.-G. Xiao
SIN-1, a Nitric Oxide Donor, Ameliorates Experimental Allergic Encephalomyelitis in Lewis Rats in the Incipient Phase: The Importance of the Time Window
J. Immunol., May 1, 2001; 166(9): 5810 - 5816.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. E. Juedes and N. H. Ruddle
Resident and Infiltrating Central Nervous System APCs Regulate the Emergence and Resolution of Experimental Autoimmune Encephalomyelitis
J. Immunol., April 15, 2001; 166(8): 5168 - 5175.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Veen, R. C.
Right arrow Articles by Holland, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Veen, R. C.
Right arrow Articles by Holland, S. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS